Folate Stress Induces Apoptosis via p53-dependent de Novo Ceramide Synthesis and Up-regulation of Ceramide Synthase 6*

Background: Sphingolipid ceramide regulates cellular responses to stress stimuli. Results: Aldh1l1, the enzyme regulating folate metabolism, leads to CerS6 up-regulation and C16-ceramide accumulation in a p53-dependent manner as a proapoptotic signal. Conclusion: Ceramide mediates the cellular response to nongenotoxic folate stress. Significance: We have demonstrated the interaction between two major metabolic pathways, folate and sphingolipids, in regulation of cellular homeostasis. We have investigated the role of ceramide in the cellular adaptation to folate stress induced by Aldh1l1, the enzyme involved in the regulation of folate metabolism. Our previous studies demonstrated that Aldh1l1, similar to folate deficiency, evokes metabolic stress and causes apoptosis in cancer cells. Here we report that the expression of Aldh1l1 in A549 or HCT116 cells results in the elevation of C16-ceramide and a transient up-regulation of ceramide synthase 6 (CerS6) mRNA and protein. Pretreatment with ceramide synthesis inhibitors myriocin and fumonisin B1 or siRNA silencing of CerS6 prevented C16-ceramide accumulation and rescued cells supporting the role of CerS6/C16-ceramide as effectors of Aldh1l1-induced apoptosis. The CerS6 activation by Aldh1l1 and increased ceramide generation were p53-dependent; this effect was ablated in p53-null cells. Furthermore, the expression of wild type p53 but not transcriptionally inactive R175H p53 mutant strongly elevated CerS6. Also, this dominant negative mutant prevented accumulation of CerS6 in response to Aldh1l1, indicating that CerS6 is a transcriptional target of p53. In support of this mechanism, bioinformatics analysis revealed the p53 binding site 3 kb downstream of the CerS6 transcription start. Interestingly, ceramide elevation in response to Aldh1l1 was inhibited by silencing of PUMA, a proapoptotic downstream effector of p53 whereas the transient expression of CerS6 elevated PUMA in a p53-dependent manner indicating reciprocal relationships between ceramide and p53/PUMA pathways. Importantly, folate withdrawal also induced CerS6/C16-ceramide elevation accompanied by p53 accumulation. Overall, these novel findings link folate and de novo ceramide pathways in cellular stress response.

[1]  R. Paules,et al.  Folate deficiency in normal human fibroblasts leads to altered expression of genes primarily linked to cell signaling, the cytoskeleton and extracellular matrix. , 2007, The Journal of nutritional biochemistry.

[2]  S. Krupenko,et al.  Ectopic expression of 10-formyltetrahydrofolate dehydrogenase in A549 cells induces G1 cell cycle arrest and apoptosis. , 2003, Molecular cancer research : MCR.

[3]  Y. Hannun,et al.  Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. , 1991, The Journal of biological chemistry.

[4]  Jian Yu,et al.  PUMA, a potent killer with or without p53 , 2008, Oncogene.

[5]  Y. Hannun,et al.  Increases in neutral, Mg2+-dependent and acidic, Mg2+-independent sphingomyelinase activities precede commitment to apoptosis and are not a consequence of caspase 3-like activity in Molt-4 cells in response to thymidylate synthase inhibition by GW1843. , 1998, Blood.

[6]  P. Codogno,et al.  Regulation of autophagy by sphingolipids. , 2011, Anti-cancer agents in medicinal chemistry.

[7]  A. Bielawska,et al.  De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation. , 2008, Prostaglandins & other lipid mediators.

[8]  J. Shinoda,et al.  Molecular mechanisms of TNF-α-induced ceramide formation in human glioma cells:P53-mediated oxidant stress-dependent and -independent pathways , 2004, Cell Death and Differentiation.

[9]  K. Hirschi,et al.  Nutrient regulation of cell cycle progression. , 2004, Annual review of nutrition.

[10]  D. Green,et al.  PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis , 2009, Cell cycle.

[11]  I. Pogribny,et al.  Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. , 1997, The American journal of clinical nutrition.

[12]  Y. Hannun,et al.  Serine Palmitoyltransferase Regulates de NovoCeramide Generation during Etoposide-induced Apoptosis* , 2000, The Journal of Biological Chemistry.

[13]  B. Ames,et al.  Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Y. Hannun,et al.  De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma Cells , 2002, The Journal of Biological Chemistry.

[15]  A. Merrill,et al.  Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. , 1991, The Journal of biological chemistry.

[16]  A. Horváth,et al.  Ceramide synthesis enhances transport of GPI‐anchored proteins to the Golgi apparatus in yeast. , 1994, The EMBO journal.

[17]  A. Bielawska,et al.  Role for Ceramide in Cell Cycle Arrest (*) , 1995, The Journal of Biological Chemistry.

[18]  A. Bielawska,et al.  Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. , 2006, Methods.

[19]  D. Priest,et al.  Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression. , 2005, The Biochemical journal.

[20]  S. Krupenko,et al.  Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway , 2007, Oncogene.

[21]  S. Nakashima,et al.  Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells , 2000, Cell Death and Differentiation.

[22]  Y. Hannun,et al.  Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B. , 1993, The Journal of biological chemistry.

[23]  Y. Hannun,et al.  Glutathione Regulation of Neutral Sphingomyelinase in Tumor Necrosis Factor-α-induced Cell Death* , 1998, The Journal of Biological Chemistry.

[24]  Jian Yu,et al.  No PUMA, no death: implications for p53-dependent apoptosis. , 2003, Cancer cell.

[25]  Y. Hannun,et al.  Many Ceramides* , 2011, The Journal of Biological Chemistry.

[26]  P. Codogno,et al.  Regulation of Autophagy by Sphingosine Kinase 1 and Its Role in Cell Survival during Nutrient Starvation* , 2006, Journal of Biological Chemistry.

[27]  Y. Asmann,et al.  Gene Expression Profiling of NF-1-Associated and Sporadic Pilocytic Astrocytoma Identifies Aldehyde Dehydrogenase 1 Family Member L1 (ALDH1L1) as an Underexpressed Candidate Biomarker in Aggressive Subtypes , 2008, Journal of neuropathology and experimental neurology.

[28]  R. Moran,et al.  The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs. , 2010, Current opinion in investigational drugs.

[29]  Mammalian ceramide synthases , 2010, IUBMB life.

[30]  A. Haimovitz-Friedman,et al.  Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis , 1994, The Journal of experimental medicine.

[31]  C. López-Larrea,et al.  Autophagy and self-defense. , 2012, Advances in experimental medicine and biology.

[32]  C. Bauvy,et al.  Ceramide-mediated Macroautophagy Involves Inhibition of Protein Kinase B and Up-regulation of Beclin 1* , 2004, Journal of Biological Chemistry.

[33]  S. Krupenko,et al.  Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress. , 2011, Genes & cancer.

[34]  A. Kihara,et al.  Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. , 2005, The Biochemical journal.

[35]  L. Obeid,et al.  Developmentally Regulated Ceramide Synthase 6 Increases Mitochondrial Ca2+ Loading Capacity and Promotes Apoptosis* , 2010, The Journal of Biological Chemistry.

[36]  Y. Hannun,et al.  Ceramide synthases at the centre of sphingolipid metabolism and biology. , 2012, The Biochemical journal.

[37]  S. Krupenko,et al.  Epigenetic Silencing of ALDH1L1, a Metabolic Regulator of Cellular Proliferation, in Cancers. , 2011, Genes & cancer.

[38]  Y. Hannun,et al.  Ceramide in apoptosis: an overview and current perspectives. , 2002, Biochimica et biophysica acta.

[39]  Y. Hannun,et al.  Antiapoptotic roles of ceramide‐synthase‐6‐generated C16‐ceramide via selective regulation of the ATF6/ CHOP arm of ER‐stress‐response pathways , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  P. Lu,et al.  Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase 3 in colon cancer cells , 2008, Oncogene.

[41]  S. Krupenko,et al.  10-Formyltetrahydrofolate Dehydrogenase–Induced c-Jun-NH2-Kinase Pathways Diverge at the c-Jun-NH2-Kinase Substrate Level in Cells with Different p53 Status , 2009, Molecular Cancer Research.

[42]  Hui-Yun Wang,et al.  Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma , 2012, Medical Oncology.

[43]  L. Obeid,et al.  The BCL-2 Protein BAK Is Required for Long-chain Ceramide Generation during Apoptosis* , 2010, The Journal of Biological Chemistry.

[44]  T. Kuwana,et al.  Sphingolipid Metabolism Cooperates with BAK and BAX to Promote the Mitochondrial Pathway of Apoptosis , 2012, Cell.

[45]  J. Selhub,et al.  Regulation of Folate-mediated One-carbon Metabolism by 10-Formyltetrahydrofolate Dehydrogenase* , 2006, Journal of Biological Chemistry.

[46]  G. Dbaibo,et al.  p53-dependent ceramide response to genotoxic stress. , 1998, The Journal of clinical investigation.

[47]  Yusuf A. Hannun,et al.  Biologically active sphingolipids in cancer pathogenesis and treatment , 2004, Nature Reviews Cancer.

[48]  S. Krupenko FDH: an aldehyde dehydrogenase fusion enzyme in folate metabolism. , 2009, Chemico-biological interactions.

[49]  L. Gu,et al.  Folate deficiency, mismatch repair-dependent apoptosis, and human disease. , 2003, The Journal of nutritional biochemistry.

[50]  L. Bailey,et al.  Folate metabolism and requirements. , 1999, The Journal of nutrition.

[51]  Y. Hannun,et al.  The complex life of simple sphingolipids , 2004, EMBO reports.

[52]  J. Pietenpol,et al.  High Affinity Insertion/Deletion Lesion Binding by p53 , 1999, The Journal of Biological Chemistry.

[53]  A. Merrill,et al.  Modulation of Ceramide Synthase Activity via Dimerization* , 2012, The Journal of Biological Chemistry.

[54]  P. Stover,et al.  Folate-mediated one-carbon metabolism. , 2008, Vitamins and hormones.

[55]  R. Testi,et al.  Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase , 1994, The Journal of experimental medicine.

[56]  J. Trepel,et al.  Impact of extracellular folate levels on global gene expression. , 2001, Molecular pharmacology.

[57]  R. Schwartz,et al.  Differentially expressed genes in embryonic cardiac tissues of mice lacking Folr1 gene activity , 2007, BMC Developmental Biology.

[58]  J. Bertino,et al.  Cancer research: from folate antagonism to molecular targets. , 2009, Best practice & research. Clinical haematology.

[59]  S. Krupenko,et al.  10-formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[60]  S. Ponnusamy,et al.  Concerted functions of HDAC1 and microRNA-574-5p repress alternatively spliced ceramide synthase 1 expression in human cancer cells , 2012, EMBO molecular medicine.

[61]  K. Scotto,et al.  Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals , 1995, Cell.

[62]  S. Krupenko,et al.  ALDH1L1 Inhibits Cell Motility Via Dephosphorylation of Cofilin by PP1 and PP2A , 2010, Oncogene.